Stockscreener 앱 받기
0.44
2.18%
-0.0098
전일 마감가:
$0.4498
열려 있는:
$0.459
하루 거래량:
74,127
Relative Volume:
0.46
시가총액:
$20.02M
수익:
$20.35M
순이익/손실:
$-59.43M
주가수익비율:
-0.4272
EPS:
-1.03
순현금흐름:
$-30.96M
1주 성능:
+2.73%
1개월 성능:
-35.86%
6개월 성능:
-37.23%
1년 성능:
-53.87%
1일 변동 폭
$0.43
$0.47
1주일 범위
$0.41
$0.47
52주 변동 폭
$0.38
$1.55
다리오 헬스 Stock (DRIO) Company Profile
명칭
Dariohealth Corp
전화
972-4-770-6377
주소
322 W 57TH ST. #33B, NEW YORK
DRIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.44 | 20.39M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
284.35 | 45.86B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
73.08 | 12.82B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
63.61 | 12.20B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.93 | 7.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.63 | 6.29B | 906.14M | -52.62M | 89.62M | -0.3621 |
다리오 헬스 Stock (DRIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2022-05-13 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2021-04-22 | 개시 | Cowen | Outperform |
| 2021-03-23 | 개시 | Stifel | Buy |
| 2021-02-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-01 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2020-08-17 | 개시 | Aegis Capital | Buy |
| 2017-08-29 | 개시 | Aegis Capital | Buy |
| 2016-05-09 | 개시 | Rodman & Renshaw | Buy |
모두보기
다리오 헬스 주식(DRIO)의 최신 뉴스
Why DarioHealth Corp. is moving todayPortfolio Return Summary & Short-Term Trading Alerts - Newser
Momentum divergence signals in DarioHealth Corp. chart2025 Investor Takeaways & Daily Price Action Insights - Newser
How moving averages guide DarioHealth Corp. tradingJuly 2025 Selloffs & Real-Time Volume Analysis - Newser
Can a trend reversal in DarioHealth Corp. lead to recoveryQuarterly Growth Report & Daily Entry Point Alerts - Newser
DarioHealth Corp. Added to High Probability Setup List2025 Market Trends & Expert-Curated Trade Recommendations - newsimpact.co.kr
DarioHealth Corp. stock volume spike explained2025 EndofYear Setup & AI Enhanced Execution Alerts - Newser
Leading vs lagging indicators on DarioHealth Corp. performance2025 Top Gainers & Smart Investment Allocation Tips - Newser
Detecting support and resistance levels for DarioHealth Corp.Quarterly Portfolio Summary & Daily Chart Pattern Signals - Newser
Can trapped investors hope for a rebound in DarioHealth Corp.Share Buyback & Growth Focused Stock Reports - Newser
DarioHealth Corp. stock prediction for this weekMarket Growth Review & Low Risk Entry Point Tips - Newser
Will DarioHealth Corp. see short term momentum2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
How Efficient Is DarioHealth Corp. at Controlling Operating CostsWeekly Trend Recap & Community Verified Swing Trade Signals - Newser
Risk adjusted return profile for DarioHealth Corp. analyzedEarnings Miss & Weekly Breakout Stock Alerts - Newser
Advanced analytics toolkit walkthrough for DarioHealth Corp.July 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - Newser
Downgrade: Here's How Analysts See DarioHealth Corp. (NASDAQ:DRIO) Performing In The Near Term - simplywall.st
Is This a Bottoming Phase for DarioHealth Corp.2025 Dividend Review & Daily Volume Surge Signals - newsimpact.co.kr
DarioHealth Corp. Outperforms Peers on Volume MetricsM&A Rumor & Verified Momentum Stock Watchlist - newsyoung.net
Trendlines Converge — Decision Point for DarioHealth Corp.2025 Volume Leaders & Expert Approved Momentum Trade Ideas - thegnnews.com
Chartists See Breakout Potential in DarioHealth Corp.July 2025 Setups & Fast Gain Stock Trading Tips - kangso.co.kr
DarioHealth 2025 Q2 Earnings Deepened Losses Despite Revenue Stabilization - AInvest
DarioHealth stock price target lowered to $1.25 at Stifel on revenue miss - Investing.com Canada
Saudi Arabia Blood Glucose Device Market Trends and Company - GlobeNewswire
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk - Yahoo Finance
Technical Heatmap Flags DarioHealth Corp. for WatchEarnings Growth Report & AI Forecast Swing Trade Picks - sundaytimes.kr
DarioHealth shares rise 1.64% premarket after Q2 2025 earnings call. - AInvest
DarioHealth Corp. (NASDAQ:DRIO) Q2 2025 Earnings Call Transcript - Insider Monkey
DarioHealth Corp. (DRIO) Reports Q2 Loss, Misses Revenue Estimates - MSN
DarioHealth Corp (DRIO) Q2 2025 Earnings Call Highlights: Strategic Client Growth Amid Revenue ... By GuruFocus - Investing.com Canada
DarioHealth Reports Increased Losses Amid Revenue Decline - TipRanks
DarioHealth's Q2 2025: Unpacking Contradictions in Revenue Growth, Efficiency, and Pharma Strategy - AInvest
Transcript : DarioHealth Corp., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
DarioHealth Corp. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:DRIO) - Seeking Alpha
Earnings call transcript: DarioHealth Q2 2025 EPS beats, stock falls on revenue miss - Investing.com
Earnings call transcript: DarioHealth Q2 2025 EPS beats, stock falls on revenue miss By Investing.com - Investing.com South Africa
DarioHealth Reports Second Quarter 2025 Financial and Operating Results - The Malaysian Reserve
Dario Q2 rev down 14.3% YoY, gross margin up to 55% YoY. - AInvest
DarioHealth earnings beat by $0.38, revenue fell short of estimates - Investing.com Canada
Digital therapeutics platform DarioHealth Q2 revenue falls steeper-than-expected 14% - MarketScreener
DarioHealth Corp. SEC 10-Q Report - TradingView
DarioHealth To Report Second Quarter 2025 Results On Tuesday, August 12, 2025 - Barchart.com
What to do if you’re stuck in DarioHealth Corp.Free Alpha Driven Watchlist With Alerts - Newser
What's Next: DarioHealth's Earnings Preview - 富途牛牛
Using Bollinger Bands to evaluate DarioHealth Corp.Buy Strategy Review With Performance Summary - Newser
Does DarioHealth Corp. fit your quant trading modelFree Real Profit Trade Plan Suggestions - Newser
DarioHealth DRIO 2025Q2 Earnings Preview Upside Potential on Strong Diabetes Management Growth - AInvest
Analyzing drawdowns of DarioHealth Corp. with statistical toolsSmart Swing Picks with Confirmed Signals - Newser
Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 25% Lower - 富途牛牛
Visual analytics tools that track DarioHealth Corp. performanceProven Trading System with Consistent Gains - Newser
DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025 - Nasdaq
DarioHealth Q2 2025 Earnings: Full Leadership Team to Present Financial Results August 12 Pre-Market - Stock Titan
DarioHealth Corp expected to post a loss of 23 cents a shareEarnings Preview - TradingView
다리오 헬스 (DRIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다리오 헬스 주식 (DRIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nelson Steven Charles | Chief Commercial Officer |
Sep 10 '24 |
Buy |
0.84 |
5,000 |
4,221 |
45,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 11 '24 |
Buy |
0.80 |
5,000 |
4,022 |
50,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 06 '24 |
Buy |
0.84 |
5,000 |
4,200 |
35,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 05 '24 |
Buy |
0.82 |
5,000 |
4,091 |
30,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 09 '24 |
Buy |
0.80 |
5,000 |
4,000 |
40,000 |
| Raphael Erez | Chief Executive Officer |
Aug 27 '24 |
Buy |
0.88 |
5,000 |
4,400 |
1,937,059 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 23 '24 |
Buy |
0.95 |
5,000 |
4,750 |
25,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 22 '24 |
Buy |
0.94 |
5,000 |
4,725 |
20,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 21 '24 |
Buy |
0.93 |
5,000 |
4,672 |
15,000 |
| Raphael Erez | Chief Executive Officer |
Aug 21 '24 |
Buy |
0.95 |
5,000 |
4,750 |
1,932,059 |
7.29%
0.75%
자본화:
|
볼륨(24시간):